menu
    • menu

    Company profile for Alfasigma

    NEW Drugs in Dev: 8
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alfasigma is one of the top 5 pharmaceutical companies in Italy, with a turnover in 2019 of more than 1 billion euros. It’s a private company with 75% owned by the family of the founder and 25% by two funds. The Alfasigma legacy is firmly anchored in a long lasting heritage of innovation and success, beginning in 1948 in Bologna (Italy) thanks to Marino Golinelli, the 100 years old philanthropist. From the beginning Alfasigm...
    Alfasigma is one of the top 5 pharmaceutical companies in Italy, with a turnover in 2019 of more than 1 billion euros. It’s a private company with 75% owned by the family of the founder and 25% by two funds. The Alfasigma legacy is firmly anchored in a long lasting heritage of innovation and success, beginning in 1948 in Bologna (Italy) thanks to Marino Golinelli, the 100 years old philanthropist. From the beginning Alfasigma has always pursued a twofold strategy: – internally, a strong focus on Research & Development and Manufacturing around some proprietary molecules, some of which represent more than 50% of the sales.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AlfasigmaItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Bologna - Via Ragazzi del ‘99, 5
    Telephone
    Telephone
    +39 0516489511
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alfasigma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alfasigma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alfasigma Pens €125M Deal For Injectable Form Of HSV Treatment
    Alfasigma Pens €125M Deal For Injectable Form Of HSV Treatment

    15 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/italys-alfasigma-pens-eu125m-deal-injectable-form-german-biotechs-hsv-treatment

    FIERCE BIOTECH
    15 Jan 2026
    Share Share
    Alfasigma Acquires Exclusive Rights To Parenteral Adibelivir
    Alfasigma Acquires Exclusive Rights To Parenteral Adibelivir

    13 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-13/alfasigma-secures-exclusive-rights-from-innovative-molecules-to-parenteral-adibelivir-for-treatment-of-hsv-encephalitis-an-ultra-rare-disease

    PHARMIWEB
    13 Jan 2026
    Share Share
    Intercept Withdraws Ocaliva for PBC from US Market, Trial on Hold
    Intercept Withdraws Ocaliva for PBC from US Market, Trial on Hold

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148535/23024/en/Intercept-Announces-Voluntary-Withdrawal-of-OCALIVA-for-Primary-Biliary-Cholangitis-PBC-from-the-US-Market-US-Clinical-Trials-Involving-Obeticholic-Acid-Placed-on-Clinical-Hold.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share
    Alfasigma's JAK Inhibitor Jyseleca Scores in Phase 3 Trial
    Alfasigma's JAK Inhibitor Jyseleca Scores in Phase 3 Trial

    30 Jul 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/alfasigma-touts-results-phase-3-trial-former-galapagos-jak-inhibitor-jyseleca

    FIERCE PHARMA
    30 Jul 2025
    Share Share
    Filgotinib Shows Results in Axial Spondyloarthritis Phase 3 Study
    Filgotinib Shows Results in Axial Spondyloarthritis Phase 3 Study

    28 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250728902063/en/Filgotinib-Shows-Positive-Topline-Results-Across-Full-Spectrum-of-Axial-Spondyloarthritis-in-OLINGUITO-Phase-3-Study

    BUSINESSWIRE
    28 Jul 2025
    Share Share
    Alfasigma Group and Fangzhou Inc. Venture into Internet Healthcare
    Alfasigma Group and Fangzhou Inc. Venture into Internet Healthcare

    19 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/forging-new-paths-alfasigma-group-and-fangzhou-inc-chart-a-course-for-internet-healthcare-302310791.html

    PR NEWSWIRE
    19 Nov 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Meprobamate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    IPPE
    Not Confirmed
    arrow

    Meprobamate

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 482

    Submission : 1962-04-26

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Naproxen Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    IPPE
    Not Confirmed
    arrow

    Naproxen Sodium

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 8436

    Submission : 1990-02-19

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Tolbutamide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    IPPE
    Not Confirmed
    arrow

    Tolbutamide

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 466

    Submission : 1962-02-15

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Sulodexide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    IPPE
    Not Confirmed
    arrow

    Sulodexide

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Samoh Pharmaceutical Co., Ltd.

    Registration Date : 2012-10-26

    Registration Number : 20121026-149-I-108-01

    Manufacturer Name : Alfasigma SpA/@OPOCRIN SpA_x000D_ @Samoh Pharmaceutical Co., Ltd.

    Manufacturer Address : Via Enrico Fermi 1-65020 Alanno (PE), Italy@Via Pacinotti, 3 41043 CORLO Di FORMIGINE (Modena), Italy_x000D_ @(135-925)7th floor, Samoh Building, 151 Yeoksam-ro, Gangnam-gu, Seoul _x000D_

     VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Sulodexide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    IPPE
    Not Confirmed
    arrow

    Sulodexide

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    IPPE
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Aju Pharmaceutical Co., Ltd.

    Registration Date : 2013-01-31

    Registration Number : 20121026-149-I-108-01(1)

    Manufacturer Name : Alfasigma SpA@ OPOCRIN SpA

    Manufacturer Address : Via ENRICO FERMI 1-65020 ALANNO(PE), ITALY@Via Pacinotti, 3 41043 CORLO Di FORMIGINE (Modena), Italy

     VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Alfasigma and get a quotation

    Alfasigma is a supplier offers 4 products (APIs, Excipients or Intermediates).

    Find a price of Meprobamate bulk offered by Alfasigma

    Find a price of Naproxen Sodium bulk offered by Alfasigma

    Find a price of Tolbutamide bulk offered by Alfasigma

    Find a price of Sulodexide bulk offered by Alfasigma

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search